clinical symptoms Allo HSCT Fever Erythroderma Hypoxemia Hypotension Other cardiac dysfunctions Capillaryleak Renal impairment GI symptoms CNS dysfunctions COVID19 sCRS 1317 76 ID: 934392
Download Presentation The PPT/PDF document "COVID-19 Percentage of CRS" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
COVID-19
Percentage
of CRS clinical symptoms
Allo-HSCT
FeverErythrodermaHypoxemiaHypotensionOther cardiac dysfunctionsCapillary-leakRenal impairmentGI symptomsCNS dysfunctions
COVID-19 sCRS13/17 (76%)0/17 (0%)17/17 (100%)7/17 (42%)5/17 (29%)0/17 (0%)3/17 (18%)3/17 (18%)0/17 (0%)Allogeneic-HSCT sCRS14/15 (93%)3/15 (20%)15/15 (100%)12/15 (80%)4/15 (27%)13/15 (87%)3/15 (20%)3/15 (20%)2/15 (13%)P value0.340.09>0.990.036>0.990.001>0.99>0.990.21
COVID-19
Allo-HSCT
COVID-19
Allo-HSCT
COVID-19
Allo-HSCT
COVID-19
Allo-HSCT
COVID-19
Allo-HSCT
COVID-19
Allo-HSCT
COVID-19
Allo-HSCT
COVID-19
Allo-HSCT
p0.001
p=0.036
A
Slide2Clinical classification of illness according to COVID-19 criteria
CRS grading classification according to Lee et al 2014 and 2018
B
COVID-19 sCRS9/17 (53%)8/17 (47%)5/17 (29%)4/17 (24%)8/17 (47%)1/17 (6%)8/17 (47%)Allogeneic-HSCT sCRSNA
NA3/15 (20%)8/15 (53%)4/15 (27%)1/15 (7%)5/15 (33%)P value--0.690.140.29>0.990.49Percentage of clinical findings